176 related articles for article (PubMed ID: 22692167)
1. The cost of drug coupons.
Grande D
JAMA; 2012 Jun; 307(22):2375-6. PubMed ID: 22692167
[No Abstract] [Full Text] [Related]
2. Specialty Drugs - A Distinctly American Phenomenon.
Naci H; Kesselheim AS
N Engl J Med; 2020 Jun; 382(23):2179-2181. PubMed ID: 32492301
[No Abstract] [Full Text] [Related]
3. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
4. Prescription drug prices in Canada.
Gross D
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
[No Abstract] [Full Text] [Related]
5. Pharmaceuticals and medical devices: Medicare Part D. Issue brief.
Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447
[No Abstract] [Full Text] [Related]
6. The cost and availability of prescription drugs--what can we do in Massachusetts?
Carpenter NW; Kedikoglou S
Issue Brief (Mass Health Policy Forum); 1999 May; (4):1-41. PubMed ID: 12769091
[No Abstract] [Full Text] [Related]
7. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
[TBL] [Abstract][Full Text] [Related]
8. Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications.
Karaca-Mandic P; Swenson T; Abraham JM; Kane RL
Health Serv Res; 2013 Aug; 48(4):1311-33. PubMed ID: 23278369
[TBL] [Abstract][Full Text] [Related]
9. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.
Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP
JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912
[TBL] [Abstract][Full Text] [Related]
10. Why using current medications to select a medicare Part D plan may lead to higher out-of-pocket payments.
Domino ME; Stearns SC; Norton EC; Yeh WS
Med Care Res Rev; 2008 Feb; 65(1):114-26. PubMed ID: 17942795
[TBL] [Abstract][Full Text] [Related]
11. Medicare Part D update--lessons learned and unfinished business.
Neuman P; Cubanski J
N Engl J Med; 2009 Jul; 361(4):406-14. PubMed ID: 19625722
[No Abstract] [Full Text] [Related]
12. Increasing Medicare part D enrollment in medication therapy management could improve health and lower costs.
Stuart B; Loh FE; Roberto P; Miller LM
Health Aff (Millwood); 2013 Jul; 32(7):1212-20. PubMed ID: 23836736
[TBL] [Abstract][Full Text] [Related]
13. How insurers' bargaining power affects drug prices in Medicare Part D.
Natl Bur Econ Res Bull Aging Health; 2009; (4):1-2. PubMed ID: 20355274
[No Abstract] [Full Text] [Related]
14. Evolutions in both co-payment and generic market share for common medication in the Belgian reference pricing system.
Fraeyman J; Verbelen M; Hens N; Van Hal G; De Loof H; Beutels P
Appl Health Econ Health Policy; 2013 Oct; 11(5):543-52. PubMed ID: 24062144
[TBL] [Abstract][Full Text] [Related]
15. Should the patent system for new medicines be abolished?
DiMasi JA; Grabowski HG
Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
[No Abstract] [Full Text] [Related]
16. Proposals to Redesign Medicare Part D - Easing the Burden of Rising Drug Prices.
Dusetzina SB; Keating NL; Huskamp HA
N Engl J Med; 2019 Oct; 381(15):1401-1404. PubMed ID: 31483987
[No Abstract] [Full Text] [Related]
17. Medicare and drug pricing.
Iglehart JK
N Engl J Med; 2003 Apr; 348(16):1590-7. PubMed ID: 12700381
[No Abstract] [Full Text] [Related]
18. A poke in the pocketbook.
Kiser K
Minn Med; 2012 Aug; 95(8):14-7. PubMed ID: 22953468
[No Abstract] [Full Text] [Related]
19. Gap in drug coverage often causes lapses in adherence to drug regimen, study shows.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):9-10, 12. PubMed ID: 15452947
[No Abstract] [Full Text] [Related]
20. Lower Prices and Greater Patient Access - Lessons from Germany's Drug-Purchasing Structure.
Robinson JC
N Engl J Med; 2020 Jun; 382(23):2177-2179. PubMed ID: 32492300
[No Abstract] [Full Text] [Related]
[Next] [New Search]